MicroRNAs (miRNAs) are small (â¼21 nucleotides), endogenous, non-coding RNA molecules implicated in the post-transcriptional gene regulation performed through target mRNA cleavage or translational inhibition. In recent years, several investigations have demonstrated that miRNAs are involved in regulating both carbohydrate and lipid homeostasis in humans and other organisms. Moreover, it has been observed that the dysregulation of these metabolism-related miRNAs leads to the development of several metabolic disorders, such as type 2 diabetes, obesity, nonalcoholic fatty liver, insulin resistance, and hyperlipidemia. Hence, in this current review, with the aim to impulse the research arena of the micro-transcriptome implications in vital metabolic pathways as well as to highlight the remarkable potential of miRNAs as therapeutic targets for metabolic disorders in humans, we provide an overview of the regulatory roles of metabolism-associated miRNAs in humans and murine models.
Glucose Metabolism Disorders/metabolism , Lipid Metabolism Disorders/metabolism , MicroRNAs/biosynthesis , Animals , Disease Models, Animal , Glucose Metabolism Disorders/genetics , Glucose Metabolism Disorders/pathology , Glucose Metabolism Disorders/therapy , Humans , Lipid Metabolism Disorders/genetics , Lipid Metabolism Disorders/pathology , Lipid Metabolism Disorders/therapy , Mice , MicroRNAs/genetics
